Literature DB >> 19645952

Upbeat-torsional nystagmus and contralateral fourth-nerve palsy due to unilateral dorsal ponto mesencephalic lesion.

Matthew J Thurtell1, Robert L Tomsak, R John Leigh.   

Abstract

The central projections of the anterior semicircular canals are thought to be conveyed from the vestibular nuclei to the oculomotor nuclei in the midbrain by three distinct brainstem pathways: the medial longitudinal fasciculus, crossing ventral tegmental tract, and brachium conjunctivum. There is controversy as to whether upbeat nystagmus could result from lesions involving each of these pathways. We report a 52-year-old man who presented with a contralesional fourth-nerve palsy and primary-position upbeat-torsional nystagmus due to a small unilateral dorsal pontomesencephalic lymphomatous deposit. It is postulated that the upbeat-torsional nystagmus was caused by involvement of the brachium conjunctivum, which lies adjacent to the fourth-nerve fascicles at the dorsal pontomesencephalic junction, but involvement of the crossing ventral tegmental tract cannot be excluded. These observations suggest that, in humans, excitatory upward-torsional eye movement signals from the anterior semicircular canals could be partly conveyed to the midbrain by the brachium conjunctivum.

Entities:  

Mesh:

Year:  2009        PMID: 19645952      PMCID: PMC2866066          DOI: 10.1111/j.1749-6632.2008.03713.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

1.  Vestibular projections to the monkey thalamus: an autoradiographic study.

Authors:  W Lang; J A Büttner-Ennever; U Büttner
Journal:  Brain Res       Date:  1979-11-09       Impact factor: 3.252

2.  A trochlear stroke.

Authors:  Achraf A Makki; Nancy J Newman
Journal:  Neurology       Date:  2005-12-27       Impact factor: 9.910

3.  Pathways for the vestibulo-ocular reflex excitation arising from semicircular canals of rabbits.

Authors:  M Ito; N Nisimaru; M Yamamoto
Journal:  Exp Brain Res       Date:  1976-01-26       Impact factor: 1.972

4.  Trochlear nerve pareses with brainstem lesions.

Authors:  J R Keane
Journal:  J Clin Neuroophthalmol       Date:  1986-12

5.  Upbeat nystagmus and the ventral tegmental pathway of the upward vestibulo-ocular reflex.

Authors:  P J Ranalli; J A Sharpe
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

6.  Connections and oculomotor projections of the superior vestibular nucleus and cell group 'y'.

Authors:  M B Carpenter; R J Cowie
Journal:  Brain Res       Date:  1985-06-17       Impact factor: 3.252

7.  The superior vestibular nucleus: an intracellular HRP study in the cat. I. Vestibulo-ocular neurons.

Authors:  A Mitsacos; H Reisine; S M Highstein
Journal:  J Comp Neurol       Date:  1983-03-20       Impact factor: 3.215

8.  Primary position upbeating nystagmus. A variety of central positional nystagmus.

Authors:  A Fisher; M Gresty; B Chambers; P Rudge
Journal:  Brain       Date:  1983-12       Impact factor: 13.501

9.  Lateropulsion and upbeat nystagmus are manifestations of central vestibular dysfunction.

Authors:  E E Benjamin; C F Zimmerman; B T Troost
Journal:  Arch Neurol       Date:  1986-09

10.  Primary position upbeat nystagmus. Another central vestibular nystagmus?

Authors:  T Nakada; M P Remler
Journal:  J Clin Neuroophthalmol       Date:  1981-09
View more
  3 in total

1.  Medullary cavernous malformation as a cause of isolated acute vestibular syndrome.

Authors:  Hyung Lee; Hyun Ah Kim
Journal:  Neurol Sci       Date:  2017-02-02       Impact factor: 3.307

2.  Hemi-seesaw nystagmus in a patient with acute infarction in the superior cerebellar artery territory.

Authors:  Hyung Lee; Hyun Ah Kim
Journal:  J Neurol       Date:  2018-03-23       Impact factor: 4.849

Review 3.  Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus.

Authors:  Michael Strupp; Matthew J Thurtell; Aasef G Shaikh; Thomas Brandt; David S Zee; R John Leigh
Journal:  J Neurol       Date:  2011-04-02       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.